Q & A
Our Q&A interviews offer investors a chance to listen a conversation with C-Suite Executives of UK-listed companies.
Share:
Oncimmune's CEO, Adam Hill, provides highlights for FY21
8th Jun 2021 14:21
0
See more in series
0